New super vaccine tested in kids to fight more pneumonia strains
NCT ID NCT06550830
Summary
This study tested a new 24-strain pneumococcal vaccine (PCV24) in 119 healthy children aged 2-17 years to see if it is safe and triggers a strong immune response. It was an early-phase trial comparing the new vaccine against an existing 13-strain vaccine in younger children. The main goal was to monitor for side effects and measure antibody levels against pneumonia-causing bacteria.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMOCOCCAL INFECTIOUS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jiangsu Provincial Center for Disease Control and Prevention (Jiangsu Provincial Academy of Preventive Medicine)
Nanjing, Jiangsu, China
Conditions
Explore the condition pages connected to this study.